ClinicalTrials.gov
ClinicalTrials.gov Menu

Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01106742
Recruitment Status : Completed
First Posted : April 20, 2010
Last Update Posted : July 19, 2011
Sponsor:
Information provided by:
Oslo University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2011
  Actual Study Completion Date : July 2011